Re-analysis of whole genome sequencing ends a diagnostic odyssey: Case report of an RNU4-2 related neurodevelopmental disorder.

RNU4‐2 WGS chromosome 12q clinical genetics deep‐phenotyping dysmorphology neurodevelopmental disorder non‐coding genome

Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
11 Jun 2024
Historique:
revised: 31 05 2024
received: 04 05 2024
accepted: 03 06 2024
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 11 6 2024
Statut: aheadofprint

Résumé

Despite increasing knowledge of disease-causing genes in human genetics, approximately half of the individuals affected by neurodevelopmental disorders remain genetically undiagnosed. Part of this missing heritability might be caused by genetic variants outside of protein-coding genes, which are not routinely diagnostically investigated. A recent preprint identified de novo variants in the non-coding spliceosomal snRNA gene RNU4-2 as a cause of a frequent novel syndromic neurodevelopmental disorder. Here we mined 164 whole genome sequencing (WGS) trios from individuals with neurodevelopmental or multiple congenital anomaly disorders that received diagnostic genomic investigations at our clinic. We identify a recurrent de novo RNU4-2 variant (NR_003137.2(RNU4-2):n.64_65insT) in a 5-year-old girl with severe global developmental delay, hypotonia, microcephaly, and seizures that likely explains her phenotype, given that extensive previous genetic investigations failed to identify an alternative cause. We present detailed phenotyping of the individual obtained during a 5-year follow-up. This includes photographs showing recognizable facial features for this novel disorder, which might allow prioritizing other currently unexplained affected individuals sharing similar facial features for targeted investigations of RNU4-2. This case illustrates the power of re-analysis to solve previously unexplained cases even when a diagnostic genome remains negative.

Identifiants

pubmed: 38859706
doi: 10.1111/cge.14574
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : ZonMw
ID : 09150172110002
Pays : Netherlands

Informations de copyright

© 2024 The Author(s). Clinical Genetics published by John Wiley & Sons Ltd.

Références

Perenthaler E, Yousefi S, Niggl E, Barakat TS. Beyond the exome: the non‐coding genome and enhancers in neurodevelopmental disorders and malformations of cortical development. Front Cell Neurosci. 2019;13:352.
Johannesen KM, Tümer Z, Weckhuysen S, Barakat TS, Bayat A. Solving the unsolved genetic epilepsies: current and future perspectives. Epilepsia. 2023;64(12):3143‐3154.
D'Haene E, Vergult S. Interpreting the impact of noncoding structural variation in neurodevelopmental disorders. Genet Med. 2021;23(1):34‐46.
Ostrander BEP, Butterfield RJ, Pedersen BS, et al. Whole‐genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy. NPJ Genom Med. 2018;3:22.
Palmer EE, Sachdev R, Macintosh R, et al. Diagnostic yield of whole genome sequencing after nondiagnostic exome sequencing or gene panel in developmental and epileptic encephalopathies. Neurology. 2021;96(13):e1770‐e1782.
Chen Y, Dawes R, Kim HC, et al. De novo variants in the non‐coding spliceosomal snRNA gene RNU4‐2 are a frequent cause of syndromic neurodevelopmental disorders. medRxiv. 2024. doi:10.1101/2024.04.07.24305438
Dekker J, Schot R, Bongaerts M, et al. Web‐accessible application for identifying pathogenic transcripts with RNA‐seq: increased sensitivity in diagnosis of neurodevelopmental disorders. Am J Hum Genet. 2023;110(2):251‐272.
Cologne A, Benoit‐Pilven C, Besson A, et al. New insights into minor splicing‐a transcriptomic analysis of cells derived from TALS patients. RNA. 2019;25(9):1130‐1149.
Perenthaler E, Nikoncuk A, Yousefi S, et al. Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi‐allelic isoform‐specific start‐loss mutations of essential genes can cause genetic diseases. Acta Neuropathol. 2020;139(3):415‐442.
Deng R, Medico‐Salsench E, Nikoncuk A, et al. AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model. Acta Neuropathol. 2023;146(2):353‐368.
Lesmann H, Hustinx A, Moosa S, et al. GestaltMatcher database ‐ a global reference for the facial phenotypic variability of rare human diseases. medRxiv. 2024. doi:10.1101/2023.06.06.23290887

Auteurs

Rachel Schot (R)

Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Discovery Unit, Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Federico Ferraro (F)

Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Geert Geeven (G)

Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Karin E M Diderich (KEM)

Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Tahsin Stefan Barakat (TS)

Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Discovery Unit, Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Classifications MeSH